Company OverviewEmerald Health Pharmaceuticals
Emerald Health Pharmaceuticals is developing proprietary product candidates to treat CNS, autoimmune, and other diseases. The Company’s technology platform consists of two families of patented new chemical entities derived from synthetic cannabidiol (CBD) and cannabigerol (CBG), two of the non-psychoactive cannabinoids, chemically modified through rational drug design to create new molecules that affect validated receptors and pathways in the body which are pertinent to targeted diseases.
EHP-101 is in Phase 2 clinical development for the treatment of systemic sclerosis, a severe form of scleroderma, and multiple sclerosis. It has received Orphan Drug designation in the US and EU and Fast Track status in the US for systemic sclerosis. EHP-102 is in preclinical development and focused on treating Parkinson’s disease and Huntington’s disease. It has received Orphan Drug designation in the US and EU for Huntington’s disease.
Speaker BioPresident & CEO
Emerald Health Pharmaceuticals
Dr. DeMesa has 30 years of experience in biotech and pharmaceutical leadership, product development, and clinical and regulatory management. He has completed partnerships and collaborations with pharmaceutical, biotech, and medical device companies and has raised more than $150 million to advance product development into clinical stage, regulatory approval, and commercialization. He is a former practicing physician and CEO of two public biotech companies: Migenix and GenSci Regeneration Sciences (now part of Integra LifeSciences).
Dr. DeMesa also currently serves as Director for two biotech companies: OncoSec Medical and Induce Biologics. Prior to his CEO roles, Dr. DeMesa was Vice President, Medical and Regulatory Affairs at Biodynamics International (now part of RTI Surgical) and Bentley Pharmaceuticals (now part of Teva Pharmaceuticals).
Dr. DeMesa received a bachelor’s degree in Chemistry, and MD, and MBA degrees from the University of South Florida and did his medical residency at the University of North Carolina.
Contact Us
Website:
http://www.emeraldpharma.life
Email:
info@emeraldhealth.ca
Phone Number:
(800)-757-3536
